A chemotherapy-free regimen offered durable disease control for certain patients with advanced breast cancer, according to results of the phase 1/phase 2 ASPIRE trial.The regimen — which consists of ...

Detailed price information for Jazz Pharma Plc (JAZZ-Q) from The Globe and Mail including charting and trades.

Ask a mining investor what kills a development timeline and most will answer with geology or the gold price. Ask a mine ...

Researchers pooled data from phase 3 BRUIN CLL-313 and BRUIN CLL-314 clinical trials to assess efficacy and safety of pirtobrutinib in treatment-naive patients with chronic lymphocytic leukemia /small ...

Discussions Around the DeLLphi-305 Trial / Amgen, Antonio Calles, AstraZeneca, cancer, DeLLphi-305, Durvalumab, ESMO, Estela ...

Dakota Gold Corp. (NYSE American: DC) ("Dakota Gold" or the "Company") is pleased to provide results from the Pre-Feasibility Study ("PFS") metallurgical test program for its Richmond Hill Oxide Heap ...

September 10, 2026) - Cabral Gold Inc.  (TSXV: CBR) (OTCQX: CBGZF) ("Cabral" or the "Company") is pleased to announce the ...

Olema Pharmaceuticals gets a Hold rating again as its current valuation reflects both potential and significant execution risks. Click for an OLMA update.

Inhibrx (INBX) updates: ozekibart & INBRX-106 show strong rare cancer and immuno-oncology data; FDA BLA due Apr 2027.

Analysts propose that this positive readout in ES-SCLC could see Imdelltra move into the frontline setting within this indication.

Ku, MD, highlights emerging therapies in the treatment paradigm for patients with gastric and gastroesophageal junction cancers. In a recent interview with Targeted Oncology, Geoffrey Y. Ku, MD, ...